Patents by Inventor Brenda Schryer

Brenda Schryer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT
    Publication number: 20140302494
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 9, 2014
    Applicant: Myriad Genetics, Incorporated
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT
    Publication number: 20130280703
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 24, 2013
    Applicant: Myriad Genetics, Incorporated
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Method of Analyzing a BRCA2 Gene in a Human Subject
    Publication number: 20090325238
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: May 15, 2009
    Publication date: December 31, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Method of Analyzing a BRCA2 Gene in a Human Subject
    Publication number: 20090325237
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: May 15, 2009
    Publication date: December 31, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Method of Analyzing a BRCA2 Gene in a Human Subject
    Publication number: 20090269814
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: March 11, 2009
    Publication date: October 29, 2009
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Novel coding sequence haplotypes of the human BRCA2 gene
    Publication number: 20060154272
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: November 7, 2005
    Publication date: July 13, 2006
    Inventors: Patricia Murphy, Marga White, Mark Rabin, Sheri Olson, Matthew Yoshikawa, Geoffrey Jackson, Tara Eskandari, Brenda Schryer, Michael Park